Ashton Tweed Connection Vol. 2 No. 5

Featuring CEO Interview with J. David Owens, CEO, BiologicsMD, Inc.

Volume 2, Number 5

Whether you are or you require executive or management talent — interim, permanent, or interim to hire — Ashton Tweed can meet your specialized retained search and executive search needs.

CEO Leadership Series: J. David Owens

Check out our new CEO Interview with J. David Owens, CEO, BiologicsMD, Inc! David Owens is an expert on reinvention and the unconventional path to the C-suite. See how he reinvented his career after 30 years of leadership in the pharmaceutical industry.

Ashton Tweed Behind the Scenes at BIO2015

Ashton Tweed Partner, Jordan Warshafsky, had the privilege to work both behind the scenes and center stage at the BIO International Convention in Philadelphia last week. Ashton Tweed was honored that Philadelphia would be hosting the world’s premiere biotechnology event, and the industry’s largest and most diverse meeting.

Biologics Vice President of R&D a Perfect Fit

A biologics company needed a VP of R&D, but no one in house qualified for this position. Due to the special nature of biological products and their difference from conventional drugs, Ashton Tweed knew this person needed to be familiar with the cutting-edge of biomedical research in order to gain the client’s full satisfaction.


	Stay Connected: Special Targeted News Go beyond the news… Get more focused information about your industry and hiring trends. Click now to enhance your subscription.

The 25 most influential people in biopharma in 2015

Every year, FierceBiotech compiles a list of the 25 most influential people in biopharma. These people are not only noteworthy leaders but are forcing this business to change for the better in fundamental ways. Who made the list?

The top 10 advertisers in Big Pharma 2015

Who are the top 10 advertisers in Big Pharma? TV ads dominate with their spending. It accounted for over 70% of total advertising spending from the top 10 pharma companies according to Nielsen data. See the list here.

Pharma Exec’s Top 50 Pharma Companies 2015

Specialty drug sales, record-breaking M&A paired with tax synergies, and global expansion helped to bring a new face into this year’s Pharma 50 top 10, and substantially boosted the rankings of several others.

5 Tips to Help Your FDA 510(k) Submission

Jon Speer, founder of greenlight.guru, is an expert at getting medical devices to market. If you’re developing a medical device in the US, chances are your path to market involves a FDA 510(k) submission. Here are his tips…

The 2015 BIO International Convention Closes in Philadelphia

This year’s Convention hosted 29,279 partnering meetings, a new record for the event. Organized by the Biotechnology Industry Organization (BIO), the event drew 15,858 industry leaders from 69 countries and 47 states, as well as the District of Columbia and Puerto Rico.

Q&A: The Future of Clinical Trial Data Sharing

The drive for the transparency of clinical trial data continues to build momentum. This mission is supported by Dr. Michael Rosenblatt, Executive VP and CMO at Merck & Co. Rosenblatt recently discussed this issue in an interview with Applied Clinical Trials.

UDI is here: 7 Things You Need to Know

Since US medical device regulators have begun implementing their Unique Device Identification (UDI) system, Emergo has identified seven key common issues to consider as you undertake UDI compliance projects. Check out the seven things you need to know.